{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11405643", "DateCompleted": {"Year": "2001", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "44", "Issue": "13", "PubDate": {"Year": "2001", "Month": "Jun", "Day": "21"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety.", "Pagination": {"StartPage": "2065", "EndPage": "2068", "MedlinePgn": "2065-8"}, "Abstract": {"AbstractText": ["A combination of demethylcantharidin, a modified component of a traditional Chinese medicine (TCM), with a platinum moiety has produced a series of TCM-based platinum compounds [Pt(C(8)H(8)O(5))(NH(2)R)(2)] 1-5, which demonstrate selective cytotoxicity toward SK-Hep-1 (human liver) cell line, and circumvention of cross-resistance. The inclusion of demethylcantharidin rendered the compounds highly active as protein phosphatase (PP2A) inhibitors. The new TCM-Pt compounds may possess a novel dual mechanism of antitumor action: inhibition of PP2A and platination of DNA."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Department of Pharmacology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, The People's Republic of China. yeepingho@cuhk.edu.hk"}], "Identifier": [], "LastName": "Ho", "ForeName": "Y P", "Initials": "YP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "To", "ForeName": "K K", "Initials": "KK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Au-Yeung", "ForeName": "S C", "Initials": "SC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "X", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lin", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Han", "ForeName": "X", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Bridged Bicyclo Compounds, Heterocyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA, Neoplasm"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Organoplatinum Compounds"}, {"RegistryNumber": "8452E71EO7", "NameOfSubstance": "norcantharidin"}, {"RegistryNumber": "EC 3.1.3.16", "NameOfSubstance": "Phosphoprotein Phosphatases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Bridged Bicyclo Compounds, Heterocyclic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA, Neoplasm"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia L1210"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Liver Neoplasms, Experimental"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Organoplatinum Compounds"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Phosphoprotein Phosphatases"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "6", "Day": "19", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "7", "Day": "13", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "19", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11405643", "10.1021/jm000476t", "jm000476t"]}}], "PubmedBookArticle": []}